Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities - PubMed (original) (raw)
Guideline
. 2009 Mar 20;58(10):256-60.
- PMID: 19300408
Free article
Guideline
Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2009.
Free article
Abstract
Infection with carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae is emerging as an important challenge in health-care settings. Currently, carbapenem-resistant Klebsiella pneumoniae (CRKP) is the species of CRE most commonly encountered in the United States. CRKP is resistant to almost all available antimicrobial agents, and infections with CRKP have been associated with high rates of morbidity and mortality, particularly among persons with prolonged hospitalization and those who are critically ill and exposed to invasive devices (e.g., ventilators or central venous catheters). This report provides updated recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC) for the control of CRE or carbapenemase-producing Enterobacteriaceae in acute care (inpatient) facilities. For all acute care facilities, CDC and HICPAC recommend an aggressive infection control strategy, including managing all patients with CRE using contact precautions and implementing Clinical and Laboratory Standards Institute (CLSI) guidelines for detection of carbapenemase production. In areas where CRE are not endemic, acute care facilities should 1) review microbiology records for the preceding 6-12 months to determine whether CRE have been recovered at the facility, 2) if the review finds previously unrecognized CRE, perform a point prevalence culture survey in high-risk units to look for other cases of CRE, and 3) perform active surveillance cultures of patients with epidemiologic links to persons from whom CRE have been recovered. In areas where CRE are endemic, an increased likelihood exists for imporation of CRE, and facilities should consider additional strategies to reduce rates of CRE. Acute care facilities should review these recommendations and implement appropriate strategies to limit the spread of these pathogens.
Similar articles
- Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH, Han WD, Song KH, Seo HK, Shin MJ, Kim TS, Park KU, Ahn S, Yoo JS, Kim ES, Kim HB. Kim NH, et al. Am J Infect Control. 2014 Dec;42(12):1270-3. doi: 10.1016/j.ajic.2014.09.004. Epub 2014 Nov 25. Am J Infect Control. 2014. PMID: 25465255 - Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
Chea N, Bulens SN, Kongphet-Tran T, Lynfield R, Shaw KM, Vagnone PS, Kainer MA, Muleta DB, Wilson L, Vaeth E, Dumyati G, Concannon C, Phipps EC, Culbreath K, Janelle SJ, Bamberg WM, Guh AY, Limbago B, Kallen AJ. Chea N, et al. Emerg Infect Dis. 2015 Sep;21(9):1611-6. doi: 10.3201/eid2109.150198. Emerg Infect Dis. 2015. PMID: 26290955 Free PMC article. - Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
Gupta N, Limbago BM, Patel JB, Kallen AJ. Gupta N, et al. Clin Infect Dis. 2011 Jul 1;53(1):60-7. doi: 10.1093/cid/cir202. Clin Infect Dis. 2011. PMID: 21653305 Review. - Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O, Ismail H, Quan V, Bamford C, Nana T, Chibabhai V, Bhola P, Ramjathan P, Swe Swe-Han K, Wadula J, Whitelaw A, Smith M, Mbelle N, Singh-Moodley A; for GERMS-SA. Perovic O, et al. Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1287-1294. doi: 10.1007/s10096-020-03845-4. Epub 2020 Mar 2. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32124106 - Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Asensio Á, Cantero M, Shaw E, Vergara-López S. Asensio Á, et al. Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:61-6. doi: 10.1016/S0213-005X(14)70176-4. Enferm Infecc Microbiol Clin. 2014. PMID: 25542054 Review.
Cited by
- Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPC.
Sheppard AE, Stoesser N, Wilson DJ, Sebra R, Kasarskis A, Anson LW, Giess A, Pankhurst LJ, Vaughan A, Grim CJ, Cox HL, Yeh AJ; Modernising Medical Microbiology (MMM) Informatics Group; Sifri CD, Walker AS, Peto TE, Crook DW, Mathers AJ. Sheppard AE, et al. Antimicrob Agents Chemother. 2016 May 23;60(6):3767-78. doi: 10.1128/AAC.00464-16. Print 2016 Jun. Antimicrob Agents Chemother. 2016. PMID: 27067320 Free PMC article. - Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution.
Tsilipounidaki K, Athanasakopoulou Z, Müller E, Burgold-Voigt S, Florou Z, Braun SD, Monecke S, Gatselis NK, Zachou K, Stefos A, Tsagalas I, Sofia M, Spyrou V, Billinis C, Dalekos GN, Ehricht R, Petinaki E. Tsilipounidaki K, et al. Microorganisms. 2022 Jan 13;10(1):159. doi: 10.3390/microorganisms10010159. Microorganisms. 2022. PMID: 35056608 Free PMC article. - Hospital epidemiology and infection control in acute-care settings.
Sydnor ER, Perl TM. Sydnor ER, et al. Clin Microbiol Rev. 2011 Jan;24(1):141-73. doi: 10.1128/CMR.00027-10. Clin Microbiol Rev. 2011. PMID: 21233510 Free PMC article. Review. - Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
Marchaim D, Chopra T, Perez F, Hayakawa K, Lephart PR, Bheemreddy S, Blunden C, Hujer AM, Rudin S, Shango M, Campbell M, Varkey J, Slim J, Ahmad F, Patel D, Chen TY, Pogue JM, Salimnia H, Dhar S, Bonomo RA, Kaye KS. Marchaim D, et al. Infect Control Hosp Epidemiol. 2011 Sep;32(9):861-71. doi: 10.1086/661597. Infect Control Hosp Epidemiol. 2011. PMID: 21828966 Free PMC article. - Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258.
Dhar S, Martin ET, Lephart PR, McRoberts JP, Chopra T, Burger TT, Tal-Jasper R, Hayakawa K, Ofer-Friedman H, Lazarovitch T, Zaidenstein R, Perez F, Bonomo RA, Kaye KS, Marchaim D. Dhar S, et al. Open Forum Infect Dis. 2016 Feb 12;3(1):ofv213. doi: 10.1093/ofid/ofv213. eCollection 2016 Jan. Open Forum Infect Dis. 2016. PMID: 26885543 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical